Home » Supporting Your Practice » Medicine » Medically Compromised Patients

Medically Compromised Patients

Oasis Case Conference: Managing a Patient with a Nasal Pharyngeal Carcinoma

The following conversation occurred between Drs. Paul Belzycki and Erin Watson, general Dentists in Toronto. Dr. Belzycki is a private practitioner and Dr. Watson is a dentist operating at Princess Margaret Hospital. The conversation is about the management of a patient with a nasal pharyngeal carcinoma and who was treated by both Drs. Belzycki and Watson. Drs. Belzycki and Watson emphasized the importance of clearly and regularly communicating between professionals to ensure the best treatment for the patient. Dr. Belzycki is accustomed to thoroughly document his cases, a fact that Dr. Watson praised and considered instrumental for the patient’s treatment ...

Read More »

ADA: Evaluation of Potentially Malignant Disorders in the Oral Cavity Clinical Practice Guideline (2017)

Adapted from the American Dental Association website A panel of experts convened by the American Dental Association (ADA) Council on Scientific Affairs presents an evidence-based clinical practice guideline called the “Evidence-Based Clinical Practice Guideline for the Evaluation of Potentially Malignant Disorders in the Oral Cavity.” The goal for this 2017 clinical practice guideline is to inform clinicians about the potential use of adjuncts as triage tools for the evaluation of lesions, including potentially malignant disorders (PMDs), in the oral cavity. Among the guideline’s recommendations: Clinicians should obtain an updated medical, social, and dental history and perform an intraoral and extraoral ...

Read More »

Managing the Pain in Temporomandibular disorders (TMD)

Dr. Aviv Ouanounou returns to Oasis Discussions to highlight valuable information he and his fellow authors, Dr. Goldberg and Dr. Haas, recently published related to the pharmacological management of patients suffering from temporomandibular disorders. He spke with Dr. Suham Alexander, CDA Oasis Clinical Editor.  Submit a question or share your feedback with us through oasisdiscussions@cda-adc.ca  Highlights Temporomandibular disorders (TMD) are prevalent in patients aged 20 – 40 years of age. It is estimated that approximately 30% of population exhibits at least 1 TMD symptom, while approximately 3 – 7% of population have TMD with more severe symptoms. Anxiety, stress and ...

Read More »

Sugar content, cariogenicity, & dental concerns with commonly used medications

It was a pleasure to host my friend Dr. Mark Donaldson to speak about a somewhat ‘less thought-about’ issue for dentists: sugar in commonly prescribed medications for dental patients. We don’t usually think about it much, but much of the medication prescribed today contains quite a bit of sugar, and dental practitioners need to take this fact into consideration when treating their patients, in particular those who are medically compromised.  If you have any questions, Dr. Donaldson would be happy to respond to those. Email us at oasisdiscussions@cda-adc.ca Chiraz Guessaier, CDA Oasis Manger Highlights Oral adverse events such as cariogenicity are often ...

Read More »

Dental Implant Survival and Complication Rate for Patients with Diabetes Mellitus

We may be in the early stages of a good news story. My interview with Dr. Thomas Oates, Professor and Chair of the Department of Advanced Oral Sciences and Therapeutics at the University of Maryland, was about a recent study he co-authored and published in Clinical Implant Dentistry & Related Research journal, titled: Dental Implant Survival and Complication Rate over 2 Years for Individuals with Poorly Controlled Type 2 Diabetes Mellitus. The study offers hope that diabetic patients could benefit from successful implant treatment without complications. I hope you enjoy the interview!  Chiraz Guessaier, CDA Oasis Manager Highlights Background Emerging evidence ...

Read More »

Hypophosphatasia: Advocating for the Patient

In the last of four segments dedicated to hypophosphatasia (HPP), Debbie Taillefer, President and Founder, Soft Bones Canada, speaks to Dr. Suham Alexander about the importance of creating a community and patient advocacy forum for patients afflicted with soft bone diseases. Highlights Soft Bones Canada was created to fill the void that Debbie and other patients required when they were newly diagnosed with HPP. Soft Bones Canada works to help support and educate patients as well as to bridge the gap with medical professionals. Dentists can play an important role in early diagnosis of the disease since the earliest signs ...

Read More »

Hypophosphatasia: A General Dentist’s Experience

Dr. Suham Alexander speaks to Dr. Bob Schroth in this third segment about hypophosphatasia (HPP) and the dental implications and management of patients with this condition. Children with HPP have some definite dental challenges. The developing teeth in these children lack cementum on the roots which leads to premature exfoliation. Additionally, large pulp chambers and irregular dentin and enamel defects increase the extent and risk of caries development. Radiographic tell-tale signs in HPP include: enlarged pulp horns, lower bone height interproximally as well as bony defects. Prudent use of dental radiographs is recommended in these patients as determined on a ...

Read More »

The Genetic Foundation of Hypophosphatasia

Dr. Cheryl Greenberg, a pediatrician and geneticist, speaks to Dr. Suham Alexander about the clinical history and manifestations of HPP in her unique patient population in Winnipeg, MB. HPP is over-represented in the Mennonite population in Manitoba due to a “founder” mutation. Highlights HPP is categorized by age of onset: perinatal, infant, juvenile, adult (systemic forms) and odonto-hypophosphatasia (dental form). All patients with HPP must have a low level of alkaline phosphatase. There is a strong genetic basis for the various forms of HPP. There are more than 300 mutations described in the literature. However, one gene is responsible for ...

Read More »